Ding, Michael
(2020)
Predicting cancer drug effectiveness with deep learning artificial intelligence.
Doctoral Dissertation, University of Pittsburgh.
(Unpublished)
Abstract
Despite advances in molecular technologies, application of precision medicine in clinical oncology remains difficult. Although widely used, single-gene biomarkers are imperfect predictors for the effective administration of targeted therapy. Meanwhile, nonspecific cytotoxic medications lack established biomarkers to guide their usage, yet they remain first-line chemotherapy for many patients. As the formulary of precision medications and tissue-agnostic treatments expands, there is a pressing and growing need for sensitive and specific companion diagnostic testing. The effective application of powerful computational techniques holds great potential for assisting clinicians and patients in the navigation of ever-increasingly complex treatment decisions.
To address this challenge, we applied state of the art deep learning techniques and modern machine learning frameworks to develop a deep neural network autoencoder for learning latent representations of integrated omics data from cancer cell lines. We used these representations to build predictive models of drug sensitivity. We evaluated the effectiveness of these models using a variety of preclinical and clinical data to assess potential for translational impact.
This research is significant in three primary ways. First, we developed a novel data-driven approach to precision medicine. Second, we demonstrated the potential for this approach to improve clinical outcomes relative the current standard of care. Third, we demonstrated that this approach not only optimizes therapeutic efficacy in preclinical cancer models, but is also generalizable to real, clinical tumors.
Share
| Citation/Export: |
|
| Social Networking: |
|
Details
| Item Type: |
University of Pittsburgh ETD
|
| Status: |
Unpublished |
| Creators/Authors: |
|
| ETD Committee: |
|
| Date: |
1 June 2020 |
| Date Type: |
Publication |
| Defense Date: |
7 April 2020 |
| Approval Date: |
1 June 2020 |
| Submission Date: |
18 May 2020 |
| Access Restriction: |
2 year -- Restrict access to University of Pittsburgh for a period of 2 years. |
| Number of Pages: |
147 |
| Institution: |
University of Pittsburgh |
| Schools and Programs: |
School of Medicine > Biomedical Informatics |
| Degree: |
PhD - Doctor of Philosophy |
| Thesis Type: |
Doctoral Dissertation |
| Refereed: |
Yes |
| Uncontrolled Keywords: |
machine learning, artificial intelligence, cancer, pharmacogenomics, deep learning |
| Date Deposited: |
01 Jun 2020 20:26 |
| Last Modified: |
01 Jun 2022 05:15 |
| URI: |
http://d-scholarship.pitt.edu/id/eprint/39052 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |
![[feed]](/images/feed-icon-32x32.png){kind=icon}